{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:06:29Z","timestamp":1794373589477,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC), a highly lethal disease with limited therapeutic options, may benefit from repurposing of FDA-approved drugs in preventive or interceptive strategies in high-risk populations. Previous animal studies demonstrated that the use of metformin and statins as single agents at relatively high doses restrained PDAC development. Here, four-week-old mice expressing KrasG12D in all pancreatic lineages (KC mice) and fed an obesogenic high fat, high calorie diet that promotes early PDAC development were randomized onto low dosage metformin, simvastatin, or both drugs in combination administered orally. Dual treatment attenuated weight gain, fibro-inflammation, and development of advanced PDAC precursor lesions (pancreatic intraepithelial neoplasia [PanIN]-3) in male KC mice, without significant effect in females or when administered individually. Dual-treated KC mice had reduced proliferation of PanIN cells and decreased transcriptional activity of the Hippo effectors, YAP and TAZ, which are important regulators of PDAC development. Metformin and simvastatin also synergistically inhibited colony formation of pancreatic cancer cells in vitro. Together, our data demonstrated that a combination of low doses of metformin and simvastatin inhibits PDAC development and imply that both drugs are promising agents for being tested in clinical trials for preventing pancreatic cancer progression.<\/jats:p>","DOI":"10.1038\/s41598-023-43498-9","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:31:46Z","timestamp":1695760306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Yaroslav","family":"Teper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Lugea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sinnett-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar J.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Rozengurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"43498_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"43498_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11\u201330. https:\/\/doi.org\/10.3322\/caac.21166 (2013).","journal-title":"CA Cancer J. Clin."},{"key":"43498_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ijc.33617","volume":"149","author":"J Yu","year":"2021","unstructured":"Yu, J., Yang, X., He, W. & Ye, W. Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039. Int. J. Cancer 149, 993\u20131001. https:\/\/doi.org\/10.1002\/ijc.33617 (2021).","journal-title":"Int. J. Cancer"},{"key":"43498_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jand.2017.07.005","volume":"118","author":"G Eibl","year":"2018","unstructured":"Eibl, G. et al. Diabetes mellitus and obesity as risk factors for pancreatic cancer. J. Acad. Nutr. Diet. 118, 555\u2013567. https:\/\/doi.org\/10.1016\/j.jand.2017.07.005 (2018).","journal-title":"J. Acad. Nutr. Diet."},{"key":"43498_CR5","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-16-0695","volume":"22","author":"A Albini","year":"2016","unstructured":"Albini, A., DeCensi, A., Cavalli, F. & Costa, A. Cancer prevention and interception: A new era for chemopreventive approaches. Clin. Cancer Res. 22, 4322\u20134327. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0695 (2016).","journal-title":"Clin. Cancer Res."},{"key":"43498_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"A Decensi","year":"2010","unstructured":"Decensi, A. et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev. Res. (Phila.) 3, 1451\u20131461. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0157 (2010).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"43498_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canep.2012.12.009","volume":"37","author":"P Zhang","year":"2013","unstructured":"Zhang, P., Li, H., Tan, X., Chen, L. & Wang, S. Association of metformin use with cancer incidence and mortality: A meta-analysis. Cancer Epidemiol. 37, 207\u2013218. https:\/\/doi.org\/10.1016\/j.canep.2012.12.009 (2013).","journal-title":"Cancer Epidemiol."},{"key":"43498_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fendo.2019.00617","volume":"10","author":"H Yu","year":"2019","unstructured":"Yu, H. et al. The potential effect of metformin on cancer: An umbrella review. Front. Endocrinol. (Lausanne) 10, 617. https:\/\/doi.org\/10.3389\/fendo.2019.00617 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"43498_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MPA.0000000000001226","volume":"48","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Statin use and risk of pancreatic cancer: An updated meta-analysis of 26 studies. Pancreas 48, 142\u2013150. https:\/\/doi.org\/10.1097\/MPA.0000000000001226 (2019).","journal-title":"Pancreas"},{"key":"43498_CR10","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2022.0014","author":"E Karbowska","year":"2022","unstructured":"Karbowska, E. et al. Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients. Cardiol. J. https:\/\/doi.org\/10.5603\/CJ.a2022.0014 (2022).","journal-title":"Cardiol. J."},{"key":"43498_CR11","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1038\/s41598-018-24337-8","volume":"8","author":"HH Chang","year":"2018","unstructured":"Chang, H. H. et al. Metformin decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity in the conditional KrasG12D mouse model. Sci. Rep. 8, 5899. https:\/\/doi.org\/10.1038\/s41598-018-24337-8 (2018).","journal-title":"Sci. Rep."},{"key":"43498_CR12","doi-asserted-by":"publisher","first-page":"e0216603","DOI":"10.1371\/journal.pone.0216603","volume":"14","author":"F Hao","year":"2019","unstructured":"Hao, F. et al. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice. PLoS ONE 14, e0216603. https:\/\/doi.org\/10.1371\/journal.pone.0216603 (2019).","journal-title":"PLoS ONE"},{"key":"43498_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"43498_CR14","doi-asserted-by":"publisher","first-page":"e0184455","DOI":"10.1371\/journal.pone.0184455","volume":"12","author":"HH Chang","year":"2017","unstructured":"Chang, H. H. et al. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLoS ONE 12, e0184455. https:\/\/doi.org\/10.1371\/journal.pone.0184455 (2017).","journal-title":"PLoS ONE"},{"key":"43498_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1940-6207.CAPR-13-0065","volume":"6","author":"DW Dawson","year":"2013","unstructured":"Dawson, D. W. et al. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev. Res. (Phila.) 6, 1064\u20131073. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0065 (2013).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"43498_CR16","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s13300-021-01058-2","volume":"12","author":"JL Tarry-Adkins","year":"2021","unstructured":"Tarry-Adkins, J. L., Grant, I. D., Ozanne, S. E., Reynolds, R. M. & Aiken, C. E. Efficacy and side effect profile of different formulations of metformin: A systematic review and meta-analysis. Diabetes Ther. 12, 1901\u20131914. https:\/\/doi.org\/10.1007\/s13300-021-01058-2 (2021).","journal-title":"Diabetes Ther."},{"key":"43498_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.6515\/acs20160611a","volume":"32","author":"S Ramkumar","year":"2016","unstructured":"Ramkumar, S., Raghunath, A. & Raghunath, S. Statin therapy: Review of safety and potential side effects. Acta Cardiol. Sin. 32, 631\u2013639. https:\/\/doi.org\/10.6515\/acs20160611a (2016).","journal-title":"Acta Cardiol. Sin."},{"key":"43498_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10555-021-09977-z","volume":"40","author":"G Eibl","year":"2021","unstructured":"Eibl, G. & Rozengurt, E. Metformin: Review of epidemiology and mechanisms of action in pancreatic cancer. Cancer Metastasis Rev. 40, 865\u2013878. https:\/\/doi.org\/10.1007\/s10555-021-09977-z (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"43498_CR19","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3748\/wjg.v25.i15.1797","volume":"25","author":"E Rozengurt","year":"2019","unstructured":"Rozengurt, E. & Eibl, G. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. World J. Gastroenterol. 25, 1797\u20131816. https:\/\/doi.org\/10.3748\/wjg.v25.i15.1797 (2019).","journal-title":"World J. Gastroenterol."},{"key":"43498_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811\u2013828. https:\/\/doi.org\/10.1016\/j.cell.2015.10.044 (2015).","journal-title":"Cell"},{"key":"43498_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2017.10.007","volume":"54","author":"G Eibl","year":"2019","unstructured":"Eibl, G. & Rozengurt, E. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops. Semin. Cancer Biol. 54, 50\u201362. https:\/\/doi.org\/10.1016\/j.semcancer.2017.10.007 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"43498_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-017-0005-2","volume":"3","author":"E Rozengurt","year":"2018","unstructured":"Rozengurt, E., Sinnett-Smith, J. & Eibl, G. Yes-associated protein (YAP) in pancreatic cancer: At the epicenter of a targetable signaling network associated with patient survival. Signal Transduct. Target Ther. 3, 11. https:\/\/doi.org\/10.1038\/s41392-017-0005-2 (2018).","journal-title":"Signal Transduct. Target Ther."},{"key":"43498_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1053\/j.gastro.2016.05.006","volume":"151","author":"R Gruber","year":"2016","unstructured":"Gruber, R. et al. YAP1 and TAZ control pancreatic cancer initiation in mice by direct up-regulation of JAK-STAT3 signaling. Gastroenterology 151, 526\u2013539. https:\/\/doi.org\/10.1053\/j.gastro.2016.05.006 (2016).","journal-title":"Gastroenterology"},{"key":"43498_CR24","doi-asserted-by":"publisher","first-page":"e114573","DOI":"10.1371\/journal.pone.0114573","volume":"9","author":"M Ming","year":"2014","unstructured":"Ming, M. et al. Dose-dependent AMPK-dependent and independent mechanisms of berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in pancreatic cancer cells. PLoS ONE 9, e114573. https:\/\/doi.org\/10.1371\/journal.pone.0114573 (2014).","journal-title":"PLoS ONE"},{"key":"43498_CR25","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.1111\/jcmm.15241","volume":"24","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway. J. Cell Mol. Med. 24, 5786\u20135796. https:\/\/doi.org\/10.1111\/jcmm.15241 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"43498_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s13046-019-1346-1","volume":"38","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Metformin targets a YAP1-TEAD4 complex via AMPKalpha to regulate CCNE1\/2 in bladder cancer cells. J. Exp. Clin. Cancer Res. 38, 376. https:\/\/doi.org\/10.1186\/s13046-019-1346-1 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"43498_CR27","doi-asserted-by":"publisher","first-page":"16759","DOI":"10.1038\/srep16759","volume":"5","author":"S Morvaridi","year":"2015","unstructured":"Morvaridi, S., Dhall, D., Greene, M. I., Pandol, S. J. & Wang, Q. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci. Rep. 5, 16759. https:\/\/doi.org\/10.1038\/srep16759 (2015).","journal-title":"Sci. Rep."},{"key":"43498_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/0897190015627255","volume":"30","author":"GK Nimako","year":"2017","unstructured":"Nimako, G. K., Wintrob, Z. A., Sulik, D. A., Donato, J. L. & Ceacareanu, A. C. Synergistic benefit of statin and metformin in gastrointestinal malignancies. J. Pharm. Pract. 30, 185\u2013194. https:\/\/doi.org\/10.1177\/0897190015627255 (2017).","journal-title":"J. Pharm. Pract."},{"key":"43498_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2337\/dc11-1829","volume":"35","author":"DM Lehman","year":"2012","unstructured":"Lehman, D. M., Lorenzo, C., Hernandez, J. & Wang, C. P. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients. Diabetes Care 35, 1002\u20131007. https:\/\/doi.org\/10.2337\/dc11-1829 (2012).","journal-title":"Diabetes Care"},{"key":"43498_CR30","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-14-0451","volume":"13","author":"MA Babcook","year":"2014","unstructured":"Babcook, M. A. et al. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol. Cancer Ther. 13, 2288\u20132302. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0451 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"43498_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ygyno.2019.05.022","volume":"154","author":"JS Kim","year":"2019","unstructured":"Kim, J. S., Turbov, J., Rosales, R., Thaete, L. G. & Rodriguez, G. C. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth. Gynecol. Oncol. 154, 432\u2013440. https:\/\/doi.org\/10.1016\/j.ygyno.2019.05.022 (2019).","journal-title":"Gynecol. Oncol."},{"key":"43498_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bbrc.2012.11.010","volume":"430","author":"J Sinnett-Smith","year":"2013","unstructured":"Sinnett-Smith, J., Kisfalvi, K., Kui, R. & Rozengurt, E. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK. Biochem. Biophys. Res. Commun. 430, 352\u2013357. https:\/\/doi.org\/10.1016\/j.bbrc.2012.11.010 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"43498_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3892\/or.2020.7909","volume":"45","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells. Oncol. Rep. 45, 1249\u20131260. https:\/\/doi.org\/10.3892\/or.2020.7909 (2021).","journal-title":"Oncol. Rep."},{"key":"43498_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1158\/1541-7786.MCR-17-0023","volume":"15","author":"F Hao","year":"2017","unstructured":"Hao, F. et al. Insulin receptor and GPCR crosstalk stimulates YAP via PI3K and PKD in pancreatic cancer cells. Mol. Cancer Res. 15, 929\u2013941. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0023 (2017).","journal-title":"Mol. Cancer Res."},{"key":"43498_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15, 73\u201379. https:\/\/doi.org\/10.1038\/nrc3876 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"43498_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/1878-0261.12498","volume":"13","author":"M Shreberk-Shaked","year":"2019","unstructured":"Shreberk-Shaked, M. & Oren, M. New insights into YAP\/TAZ nucleo-cytoplasmic shuttling: New cancer therapeutic opportunities?. Mol. Oncol. 13, 1335\u20131341. https:\/\/doi.org\/10.1002\/1878-0261.12498 (2019).","journal-title":"Mol. Oncol."},{"key":"43498_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3389\/fphys.2019.01467","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu, C. et al. Yes-associated protein 1 plays major roles in pancreatic stellate cell activation and fibroinflammatory responses. Front. Physiol. 10, 1467. https:\/\/doi.org\/10.3389\/fphys.2019.01467 (2019).","journal-title":"Front. Physiol."},{"key":"43498_CR38","doi-asserted-by":"publisher","first-page":"e0141392","DOI":"10.1371\/journal.pone.0141392","volume":"10","author":"J Incio","year":"2015","unstructured":"Incio, J. et al. Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages. PLoS ONE 10, e0141392. https:\/\/doi.org\/10.1371\/journal.pone.0141392 (2015).","journal-title":"PLoS ONE"},{"key":"43498_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.canlet.2016.10.019","volume":"385","author":"W Duan","year":"2017","unstructured":"Duan, W. et al. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Cancer Lett. 385, 225\u2013233. https:\/\/doi.org\/10.1016\/j.canlet.2016.10.019 (2017).","journal-title":"Cancer Lett."},{"key":"43498_CR40","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/s0006-2952(03)00075-3","volume":"65","author":"R Jaster","year":"2003","unstructured":"Jaster, R., Brock, P., Sparmann, G., Emmrich, J. & Liebe, S. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem. Pharmacol. 65, 1295\u20131303. https:\/\/doi.org\/10.1016\/s0006-2952(03)00075-3 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"43498_CR41","doi-asserted-by":"publisher","first-page":"G763","DOI":"10.1152\/ajpgi.00170.2019","volume":"317","author":"TS Dong","year":"2019","unstructured":"Dong, T. S. et al. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G763\u2013G772. https:\/\/doi.org\/10.1152\/ajpgi.00170.2019 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"43498_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58030430","author":"I Ilias","year":"2022","unstructured":"Ilias, I., Rizzo, M. & Zabuliene, L. Metformin: Sex\/gender differences in its uses and effects-narrative review. Medicina (Kaunas) https:\/\/doi.org\/10.3390\/medicina58030430 (2022).","journal-title":"Medicina (Kaunas)"},{"key":"43498_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40264-020-00913-8","volume":"43","author":"ST de Vries","year":"2020","unstructured":"de Vries, S. T., Denig, P., Ekhart, C., Mol, P. G. M. & van Puijenbroek, E. P. Sex differences in adverse drug reactions of metformin: A longitudinal survey study. Drug Saf. 43, 489\u2013495. https:\/\/doi.org\/10.1007\/s40264-020-00913-8 (2020).","journal-title":"Drug Saf."},{"key":"43498_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/geroni\/igaa057.1673","volume":"4","author":"CVL Teixeira","year":"2020","unstructured":"Teixeira, C. V. L. et al. Sex differences in response to metformin in a longitudinal study in mice. Innov. Aging 4, 518. https:\/\/doi.org\/10.1093\/geroni\/igaa057.1673 (2020).","journal-title":"Innov. Aging"},{"key":"43498_CR45","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1172\/JCI79573","volume":"125","author":"X Zhou","year":"2015","unstructured":"Zhou, X. et al. Estrogen regulates Hippo signaling via GPER in breast cancer. J. Clin. Investig. 125, 2123\u20132135. https:\/\/doi.org\/10.1172\/JCI79573 (2015).","journal-title":"J. Clin. Investig."},{"key":"43498_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jcmgh.2020.04.016","volume":"10","author":"CA Natale","year":"2020","unstructured":"Natale, C. A. et al. Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma. Cell Mol. Gastroenterol. Hepatol. 10, 868-880 e861. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.04.016 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"43498_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban, R. H. et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579\u2013586 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"43498_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/0008-5472.CAN-05-2168","volume":"66","author":"RH Hruban","year":"2006","unstructured":"Hruban, R. H. et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: Consensus report and recommendations. Cancer Res. 66, 95\u2013106. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2168 (2006).","journal-title":"Cancer Res."},{"key":"43498_CR49","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43498-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43498-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43498-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:20:32Z","timestamp":1700407232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43498-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43498"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43498-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16144"}}